What is BioZyme?
BioZyme Inc operates as a specialized manufacturer of advanced animal nutrition and health solutions, catering to a broad spectrum of species including cattle, goats, hogs, sheep, horses, and canines. The company distinguishes itself through proprietary innovations such as Amaferm, VitaFerm, Sure Champ, and Vitalize, which are engineered to optimize digestive health and overall performance in livestock. By serving a diverse demographic ranging from commercial ranchers to show animal enthusiasts, BioZyme maintains a critical role in the agricultural supply chain. Their commitment to sustainable farming practices and rigorous research-backed product development positions them as a leader in the intersection of animal welfare and commercial productivity.
How much funding has BioZyme raised?
BioZyme has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in BioZyme
PPP
Public-Private Partnership
What's next for BioZyme?
With the recent infusion of capital, BioZyme is strategically positioned to scale its research and development initiatives, focusing on the next generation of prebiotic and probiotic supplements. The company is expected to prioritize market penetration in the equine and commercial dairy sectors, where demand for high-performance nutritional additives remains elevated. Furthermore, the firm will likely utilize this financial backing to enhance its community advocacy programs and strengthen its distribution networks, ensuring that its sustainable agriculture mission reaches a wider global audience. As the company transitions into this new phase of growth, the focus will remain on maintaining product efficacy while navigating the complexities of the modern agricultural landscape.
See full BioZyme company page
